Search Results for: us stem cell

Stemgenex motion to dismiss aims to rebut stem cell suit claims

/ / 1 Comment
Motion-to-dismiss-Stemgenex-e1481238888500

San Diego-based stem cell business Stemgenex is the subject of a suit over allegations about stem cell treatments. The company has now filed a motion to dismiss the case. To me as a non-attorney, the Stemgenex motion to dismiss seems to emphasize overall vagueness of the plaintiff’s case and argues in part that there is insufficient detailed support of each claim. From […]

Stemgenex motion to dismiss aims to rebut stem cell suit claims Read More »

Stem cell clinic lawsuits proliferate with latest against Stemgenex

/ / 8 Comments
StemGenex

There is a growing trend of apparently unhappy patients suing stem cell clinics, which have faced more lawsuits recently and some of these cases are proposed class action suits that could have much broader impact. The latest case is against San Diego-based Stemgenex, a clinic that has claimed amongst other things that it can treat numerous diverse afflictions and that

Stem cell clinic lawsuits proliferate with latest against Stemgenex Read More »

20 Nominees for Stem Cell Person of the Year 2016 Award

/ / 4 Comments
Stem-cell-person-of-the-year-award

I received a score of great nominations for the Stem Cell Person of the Year 2016 Award and have briefly described the twenty nominees below. The point of the award is to honor the top positive stem cell leader who specifically thinks outside the box and takes risks. I’ve started an on-line vote where you can vote once per day for

20 Nominees for Stem Cell Person of the Year 2016 Award Read More »

Perspectives on Cures Act stem cell provisions possible benefits & risks

/ / 6 Comments
EnergyCommerceLogo_ORANGE-e1480522761962

The 21st Century Cures Act has some important provisions that would impact the stem cell and regenerative medicine field.  What is driving these efforts is a widespread sense that the status quo of regenerative medicine oversight isn’t working very well. I’m talking with key stakeholders and still trying to sort out my thoughts on the

Perspectives on Cures Act stem cell provisions possible benefits & risks Read More »

A feast of post-Thanksgiving stem cell news bites

/
rainbow-cells-1

Rainbow stem cell clones. From Scientific Reports: NF-kappaΒ-inducing kinase regulates stem cell phenotype in breast cancer. How to harvest stem cells from teeth Stem Cell Transplant Startup With Harvard Tech, Magenta Therapeutics, Gets $48.5M Neurogenic Radial Glia-like Cells in Meninges Migrate and Differentiate into Functionally Integrated Neurons in the Neonatal Cortex (from Cell Stem Cell). Researchers Grow Functioning Human Intestines, Nerves Using Stem

A feast of post-Thanksgiving stem cell news bites Read More »

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate

/ / 4 Comments
Harada-Family-e1479769086296

It takes a great deal of courage to participate in a clinical trial, patients who make that choice are heroes in my book and one such hero with stem cells was Ted Harada who had ALS. Sadly, Ted passed away from a brain tumor called glioblastoma last month. When enrolling in a trial, you just never

Tribute to Ted Harada, pioneering stem cell trial participant and ALS advocate Read More »

SCOTS Study on Stem Cells for Vision: Still Questions as Patient Alleges Harm

/ / 2 Comments
Eye-injection-e1478306814439

I’m hearing more questions from the community about alleged harm from stem cell clinics selling stem cells for a number of vision-related conditions and some concerns include the so-called SCOTS study. I first blogged about SCOTS early this year and back then I myself had questions too. Some commenters then raised concerns or questions about SCOTS in

SCOTS Study on Stem Cells for Vision: Still Questions as Patient Alleges Harm Read More »

Trump Has FDA in Crosshairs: Impact on Stem Cell Oversight?

/ / 1 Comment
FDA-Trump-Healthcare

Will Trump trump the FDA? Our President-elect recently released his health care policy agenda and it looks like the FDA is a target in terms of reducing oversight. Over at the Washington Post, Carolyn Johnson has a nice article on this development. One point in the agenda in particular has caught people’s attention as potentially the key

Trump Has FDA in Crosshairs: Impact on Stem Cell Oversight? Read More »

Internal FDA Fighting on Sarepta Bad Omen for Stem Cell Oversight?

/ / 8 Comments
Exondys-51-Sarepta-

The FDA caused major controversy by approving the drug Exondys 51 from Sarepta Therapeutics for treating Duchenne muscular dystrophy over the recommendations of a scientific panel it convened that had voted 7-3 against approval. Is this contentious Sarepta approval serve as a sign of how the FDA will deal with stem cells moving forward? Will the FDA approval, which

Internal FDA Fighting on Sarepta Bad Omen for Stem Cell Oversight? Read More »

REGROW Act, Mark Kirk Lobbying & Contributions Yield Stem Cell Surprises

/ / 1 Comment
Center-for-Responsive-Politics

The money behind a piece of legislation can provide unique insights into the back story and this is definitely true for the REGROW Act that would reduce FDA oversight of the investigational use of stem cells in patients. Senator Mark Kirk of Illinois, who is facing probable defeat next week in his reelection bid according to

REGROW Act, Mark Kirk Lobbying & Contributions Yield Stem Cell Surprises Read More »